Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-ge... Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-genital, glioblastoma multiforme, lung, and ovarian cancers; and human papilloma virus. It is also involved in the development of INV043, which is in Phase II clinical trial for the treatment of patients with prostate cancer; and in Phase I/II clinical trial to treat non-melanoma skin cancer, as well as for the treatment of oesophageal cancer. The company has collaborations with Hudson Institute of Medical Research, Peter MacCallum Cancer Centre, Dr. I&B Co., Ltd., and Hanlim Pharm Co., Ltd. Invion Limited was incorporated in 2000 and is headquartered in Melbourne, Australia. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0.0369 | 0.0369 | 0.0369 | 0 | 0 | CS |
| 26 | 0 | 0 | 0.0369 | 0.0369 | 0.0369 | 0 | 0 | CS |
| 52 | 0 | 0 | 0.0369 | 0.0369 | 0.0369 | 1 | 0.0369 | CS |
| 156 | 0.03217 | 680.126849894 | 0.00473 | 0.0369 | 0.0022 | 12428 | 0.00311477 | CS |
| 260 | 0.026687 | 261.304220112 | 0.010213 | 0.0369 | 0.0022 | 21706 | 0.01276757 | CS |
pistol2
5分前
Blish
6分前
MrMontag
8分前
ron_66271
8分前
KngmAz
10分前
MarketMindset
11分前
crossball
12分前
disgusted investor
12分前
SSKILLZ1
16分前
DrHigh
18分前
MarketMindset
19分前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。